Diagnostic and Perioperative Complexity when Retroperitoneal Hemangioma Mimics Sympathetic Paraganglioma: A Case Report
This case report describes a 52-year-old man whose retroperitoneal cavernous hemangioma mimicked a functional sympathetic paraganglioma due to hypertension and equivocal catecholamine levels, necessitating a high-risk perioperative alpha-blockade protocol and laparoscopic resection to safely manage the potential for a functional tumor despite the final benign, non-functional histopathology.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the deep space behind the abdominal organs, known as the retroperitoneum, tumors can sometimes grow that are difficult to identify. These masses are rare, and their appearance on medical scans often looks like many different things, making it hard for doctors to know exactly what they are dealing with before surgery. One of the most critical challenges in this area involves distinguishing between a harmless blood vessel tumor and a rare, hormone-producing tumor called a paraganglioma. If a tumor produces hormones that spike blood pressure, removing it without special preparation can cause a dangerous crash in the patient's cardiovascular system. Because of this risk, surgeons must often treat a suspicious mass as if it were dangerous, even if it turns out to be benign. This careful balancing act between safety and certainty is at the heart of a recent medical case that highlights how complex patient history can blur the lines between a routine operation and a high-stakes emergency.
A 52-year-old man arrived at the hospital with a medical history that included insulin-dependent diabetes, high blood pressure, and a mood disorder. He had no family history of cancer, but a routine scan taken after a car accident revealed a well-vascularized mass in his retroperitoneum. The mass was sitting near the large vein that carries blood from the lower body to the heart and was pressing against part of the intestine. While the scan showed a rich network of blood vessels, it could not definitively say what the mass was. The real concern arose from the patient's blood work. Tests showed slightly elevated levels of chemicals in his urine and blood that are typically released by the body during stress or by hormone-secreting tumors. Combined with his existing high blood pressure and a history of anxiety, the medical team faced a difficult puzzle: was this a benign growth, or was it a functional tumor that could trigger a life-threatening surge in blood pressure during surgery?
The medical team decided to proceed with the highest level of caution. They treated the patient as though the mass were a functional paraganglioma, a tumor that secretes stress hormones. This meant starting a specific regimen of medication to block the effects of those hormones before the operation. The patient was given drugs to block alpha-adrenergic receptors, which help control blood vessel constriction, followed by beta-blockers to manage heart rate. This preparation is standard for hormone-secreting tumors because it prevents a sudden, catastrophic rise in blood pressure when the tumor is touched or removed. The team also worked to manage his blood sugar, which had been difficult to control for years, with recent tests showing an average blood glucose level of 266 milligrams per deciliter. Despite these efforts, the patient's blood sugar remained high, and his blood pressure stayed elevated, adding another layer of risk to the procedure.
The surgery was performed using a minimally invasive approach, where small incisions allowed the surgeon to remove the mass with a specialized tool. The operation went smoothly, and the mass, which weighed 92 grams and measured roughly 6.5 by 6.3 by 3.7 centimeters, was removed intact. There was no sign that the tumor had invaded nearby organs. Once the mass was out, the patient was moved to a recovery area in stable condition. However, the postoperative period did not follow the typical pattern seen with hormone-secreting tumors. Usually, after such a tumor is removed, patients experience a sudden drop in blood pressure as the hormone supply is cut off. Instead, this patient remained hypertensive, with systolic pressures hovering between 140 and 150 millimeters of mercury, and his blood sugar levels continued to fluctuate wildly.
When the removed tissue was examined under a microscope, the mystery was finally solved. The mass was not a hormone-secreting tumor at all. It was a cavernous hemangioma, a benign collection of dilated blood vessels lined by a single layer of cells. There was no evidence of the neuroendocrine tissue that characterizes paragangliomas. The elevated hormone levels seen before the surgery were likely a result of the patient's chronic high blood pressure, his anxiety, and the physical stress of his recent car accident, rather than the tumor itself. The diagnosis was confirmed as a benign vascular lesion, and follow-up imaging one month later showed no signs of the mass returning.
This case illustrates a vital lesson in surgical medicine: when the evidence is ambiguous, the safest path is to prepare for the worst-case scenario. The combination of a hypervascular mass, borderline hormone levels, and a patient with a history of hypertension and anxiety created a convincing picture of a dangerous tumor. Even though the final result was a harmless growth, the decision to use extensive preoperative medication was justified. Unprepared removal of a true hormone-secreting tumor carries a high risk of death, whereas the risks associated with the medication for a benign tumor are manageable. The patient's difficult diabetes and persistent high blood pressure further complicated the picture, showing how other health conditions can mimic the signs of a rare disease. Ultimately, the only way to know for sure what a retroperitoneal mass is remains the microscopic examination of the tissue after it has been removed, but until that moment, surgeons must rely on careful preparation to ensure the patient survives the journey.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.